Lexeo Therapeutics Inc. (LXEO)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
4. 69
+0.13
+2.8509%
$
362.77M Market Cap
- P/E Ratio
- Div Yield
730,100 Volume
- Eps
$ 4.56
Previous Close 
Want to track LXEO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
LXEO Earnings Reports FAQ
What is the earnings per share (EPS) for LXEO?
EPS data for LXEO is currently not available, as Lexeo Therapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Lexeo Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Lexeo Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Lexeo Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LXEO at this time, as Lexeo Therapeutics Inc has no recent EPS data to calculate it.
